[1] SIBEY SD,PALMER JP,HIRSEH IB,et al. Visceral obesity,hepatic lipase activity,and dyslipidemia in type 1 diabetes[J]. J Clin Endoerinol Metab,2003,88(7):3379-3384. [2] KURIYAMA S,MIWA Y,FUKUSHIMA H,et al. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease[J]. J Clin Biochem Nutr,2007,40(2):116-122. [3] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案[J]. 中华内科杂志,2001,40(1):62-68. [4] 姜丽萍,赵金满. 肝源性糖尿病的诊断与治疗[J]. 世界华人消化杂志,2007,15(6):617-621. [5] 陈灏珠. 实用内科学[M]. 11版. 北京:人民卫生出版社,2002:958. [6] 黄涛,秦波. 肝源性胰岛素抵抗的研究进展[J]. 世界华人消化杂志,2008,16(6):653-657. [7] RDDDATZ D,ROSBACH C,BUCHWALD A,et al. Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts(TIPs)[J]. Exp Clin Endocrinol Diabetes,2008,116(8):461-467. [8] GARCIA-COMPEAN D,JAQUEZ-QUINTANA J, MALDONADO-GARAZA H. Hepatogenous diabetes.Current views of an ancient problem[J]. Ann Hepatol,2009,8(1):13-20. [9] 张萍,杨雁. 肝源性糖尿病的研究现况[J]. 华中科技大学学报(医学版),2010,39(1):136-139. [10] 江水清,胡孝彬,李玉芝,等. 76例肝源性糖尿病临床特点分析[J]. 实用肝脏病杂志,2009,12(4):292-293. [11] FUJIWARA F,ISHII M,TANEICHI H,et al. Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus[J]. Tohoku J Exp Med,2005,205(4):327-334. |